Saratoga Health & Biotechnology Portfolio Fund Class C
SHPCX
NASDAQ
| Weiss Ratings | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Saratoga | |||
| Manager/Tenure (Years) | Robert D. Stimpson (6) | |||
| Website | http://www.saratogacap.com/ | |||
| Fund Information | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Saratoga Health & Biotechnology Portfolio Fund Class C | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jan 18, 2000 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 250.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | 0.01 | |||
| Dividends and Shares | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.28% | |||
| Asset Allocation | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 5.46% | |||
| Stock | 94.53% | |||
| U.S. Stock | 90.23% | |||
| Non-U.S. Stock | 4.30% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.42% | |||
| 30-Day Total Return | -1.96% | |||
| 60-Day Total Return | -3.56% | |||
| 90-Day Total Return | 0.40% | |||
| Year to Date Total Return | -1.42% | |||
| 1-Year Total Return | -7.52% | |||
| 2-Year Total Return | 0.55% | |||
| 3-Year Total Return | 4.30% | |||
| 5-Year Total Return | 18.51% | |||
| Price | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $12.45 | |||
| 1-Month Low NAV | $12.45 | |||
| 1-Month High NAV | $13.02 | |||
| 52-Week Low NAV | $12.06 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $14.74 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.60 | |||
| Standard Deviation | 13.89 | |||
| Balance Sheet | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 10.18M | |||
| Operating Ratios | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 3.32% | |||
| Turnover Ratio | 17.00% | |||
| Performance | SHPCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.25% | |||
| Last Bear Market Total Return | -6.37% | |||